Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe

摘要

We report 2 cases of leishmaniasis in patients with au-toimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Re-ports increased during 2004–2008, especially for patients treated with anti–tumor necrosis factor agents